List of Excipients in API treprostinil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing treprostinil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | HYDROCHLORIC ACID | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | METACRESOL | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | SODIUM CHLORIDE | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | SODIUM HYDROXIDE | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | TRISODIUM CITRATE DIHYDRATE | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | WATER | |
| United Therapeutics Corporation | REMODULIN | treprostinil | 66302-111 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing treprostinil
Detailed excipient profiles for treprostinil
Excipient focus: ALCOHOL
treprostinil drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing ALCOHOL
Excipient focus: BUTYL ALCOHOL
treprostinil drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE ACETATE
treprostinil drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing CELLULOSE ACETATE
Excipient focus: FERROSOFERRIC OXIDE
treprostinil drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FUMARYL DIKETOPIPERAZINE
treprostinil drug variants containing FUMARYL DIKETOPIPERAZINE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing FUMARYL DIKETOPIPERAZINE
Excipient focus: HYDROCHLORIC ACID
treprostinil drug variants containing HYDROCHLORIC ACID
treprostinil drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
treprostinil drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
treprostinil drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
treprostinil drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing MALTODEXTRIN
Excipient focus: METACRESOL
treprostinil drug variants containing METACRESOL
treprostinil drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-206 |
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
treprostinil drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYVINYL ALCOHOL
treprostinil drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing POLYVINYL ALCOHOL
Excipient focus: PROPYLENE GLYCOL
treprostinil drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
treprostinil drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing SHELLAC
Excipient focus: SODIUM CHLORIDE
treprostinil drug variants containing SODIUM CHLORIDE
treprostinil drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
treprostinil drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
| Sandoz Inc | treprostinil | 0781-3420 |
| Alembic Pharmaceuticals Inc | treprostinil | 62332-514 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
treprostinil drug variants containing SODIUM HYDROXIDE
treprostinil drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
treprostinil drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TALC
treprostinil drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
treprostinil drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIETHYL CITRATE
treprostinil drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing TRIETHYL CITRATE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
treprostinil drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | treprostinil | 42023-209 |
| DrReddy's Laboratories Inc | treprostinil | 43598-649 |
| United Therapeutics Corporation | treprostinil | 66302-101 |
| United Therapeutics Corporation | treprostinil | 66302-111 |
| United Therapeutics Corporation | treprostinil | 66302-206 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
| Sandoz Inc | treprostinil | 0781-3420 |
| Alembic Pharmaceuticals Inc | treprostinil | 62332-514 |
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
treprostinil drug variants containing WATER
treprostinil drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | treprostinil | 0781-3420 |
| United Therapeutics Corporation | treprostinil | 66302-300 |
| United Therapeutics Corporation | treprostinil | 66302-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: XYLITOL
treprostinil drug variants containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| United Therapeutics Corporation | treprostinil | 66302-300 |
| >Company | >Ingredient | >NDC |
treprostinil drug variants not containing XYLITOL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
